Article ; Online: The current and future aspects of glioblastoma: Immunotherapy a new hope?
The European journal of neuroscience
2021 Volume 54, Issue 3, Page(s) 5120–5142
Abstract: Glioblastoma (GBM) is the most perilous and highly malignant in all the types of brain tumor. Regardless of the treatment, the diagnosis of the patients in GBM is very poor. The average survival rate is only 21 months after multimodal combinational ... ...
Abstract | Glioblastoma (GBM) is the most perilous and highly malignant in all the types of brain tumor. Regardless of the treatment, the diagnosis of the patients in GBM is very poor. The average survival rate is only 21 months after multimodal combinational therapies, which include chemotherapy, radiation, and surgery. Due to the intrusive and infiltrative nature of GBM, it requires elective therapy for specific targeting of tumor cells. Tumor vaccine in a form of immunotherapy has potential to address this need. Nanomedicine-based immunotherapies have clutch the trigger of systemic and specific immune response against tumor cells, which might be the approach to eliminating the unrelieved cancer. In this mechanism, combination of immunomodulators with specific target and appropriate strategic vaccines can stifle tumor anti-immune defense system and/or increase the capabilities of the body to move up immunity against the tumor. Here, we explore the different types of immunotherapies and vaccines for brain tumor treatment and their clinical trials, which bring the feasibility of the future of personalized vaccine of nanomedicine-based immunotherapies for the brain tumor. We believe that immunotherapy could result in a significantly more stable reaction in GBM patients. |
---|---|
MeSH term(s) | Brain Neoplasms/therapy ; Cancer Vaccines ; Glioblastoma/therapy ; Humans ; Immunologic Factors ; Immunotherapy |
Chemical Substances | Cancer Vaccines ; Immunologic Factors |
Language | English |
Publishing date | 2021-06-29 |
Publishing country | France |
Document type | Journal Article ; Review |
ZDB-ID | 645180-9 |
ISSN | 1460-9568 ; 0953-816X |
ISSN (online) | 1460-9568 |
ISSN | 0953-816X |
DOI | 10.1111/ejn.15343 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2548: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.